Sandbox/table: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
{| style="font-size: | {| style="border: 2px solid #DCDCDC; font-size: 90%; width: 80%;" | ||
|+ '''Laboratory findings''' | |||
|- | |- | ||
! style="width: 80px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Test}} | |||
! style="width: 720px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Findings}} | |||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[ | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[White blood cells]] count''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| Leucopenia (1000 cells/μL), with lymphopenia and neutrophilia | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[ | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Blood smear]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| Left shift with atypical lymphocytes | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[ | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver function tests]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| [[ | | style="background: #DCDCDC; padding: 5px;"| Raised [[aspartate aminotransferase]] and [[alanine aminotransferase]], extended [[prothrombin time]] and [[partial thromboplastin time]]. | ||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Proteins]]''' | |||
| style="background: #DCDCDC; padding: 5px;"| [[Hyperproteinemia]]. | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Urinalysis]]''' | |||
| style="background: #DCDCDC; padding: 5px;"| [[Proteinuria]]. | |||
|} | |} | ||
Revision as of 18:58, 20 June 2014
The following table contains the main risk factors for CDI:[1][2][3][2][2]
Alterations in the coagulation system |
---|
Consumption of clotting factors |
Increased concentrations of fibrin degradation products |
Disseminated intravascular coagulation |
Test | Findings |
---|---|
White blood cells count | Leucopenia (1000 cells/μL), with lymphopenia and neutrophilia |
Blood smear | Left shift with atypical lymphocytes |
Liver function tests | Raised aspartate aminotransferase and alanine aminotransferase, extended prothrombin time and partial thromboplastin time. |
Proteins | Hyperproteinemia. |
Urinalysis | Proteinuria. |
table
Diagnostic test | North America | South America | Middle East | Far East |
---|---|---|---|---|
ELISA (serology) detects:
|
† There is a reported prevalence of 15% in the Northeast of the US.
- ↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
- ↑ 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
- ↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.